dc.contributor.author |
Lipp, Hans-Peter |
|
dc.date.accessioned |
2015-11-17T09:25:32Z |
|
dc.date.available |
2015-11-17T09:25:32Z |
|
dc.date.issued |
2015 |
|
dc.identifier.issn |
0939-5555 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/66513 |
|
dc.language.iso |
en |
en |
dc.publisher |
Springer |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1007/s00277-015-2333-z |
|
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
Therapeutic drug monitoring in the treatment of invasive aspergillosis with voriconazole in cancer patients-an evidence-based approach |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20150901145020_01209 |
|
utue.publikation.seiten |
547-556 |
de_DE |
utue.personen.roh |
Karthaus, Meinolf |
|
utue.personen.roh |
Lehrnbecher, Thomas |
|
utue.personen.roh |
Lipp, Hans-Peter |
|
utue.personen.roh |
Kluge, Stefan |
|
utue.personen.roh |
Buchheidt, Dieter |
|
dcterms.isPartOf.ZSTitelID |
Annals of Hematology |
de_DE |
dcterms.isPartOf.ZS-Issue |
4 |
de_DE |
dcterms.isPartOf.ZS-Volume |
94 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
|